AnalystsLucas WardLucas Ward's Stock Forecasts
AnalystsLucas Ward
Analyst Ranking
Bottom 4%
#4775 out of 4929 analysts
Average Return
-30.12%
Win Rate
35%7 out of 20
Risk vs Reward
Poor
Good
Lucas Ward's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Vivos Therapeutics IncVVOS | +102.28% | $2.19 | $4.43 | 2025-04-15 - 2025-07-03 | Buy |
Vivos Therapeutics IncVVOS | +53.29% | $2.89 | $4.43 | 2024-11-19 - 2025-07-03 | Buy |
Vivos Therapeutics IncVVOS | +45.25% | $3.05 | $4.43 | 2024-08-20 - 2025-07-03 | Buy |
Heartsciences IncHSCS | +21.43% | $2.94 | $3.57 | 2024-09-23 - 2025-07-03 | Buy |
Heartsciences IncHSCS | +13.33% | $3.15 | $3.57 | 2025-03-18 - 2025-07-03 | Buy |
Lucas Ward Analyst Color
Get additional color on Lucas Ward's coverage of popular stocks
Lucas Ward's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Liqtech International IncLIQT | 5 | Buy | $3.60 | +118.18% | Maintains | 19 days ago |
60 Degrees Pharmaceuticals IncSXTP | 2 | Buy | $7.00 | +194.12% | Maintains | a month ago |
Vivos Therapeutics IncVVOS | 3 | Buy | $6.20 | +39.95% | Maintains | 3 months ago |
Heartsciences IncHSCS | 2 | Buy | $14.00 | +292.16% | Maintains | 4 months ago |
Aclarion IncACON | 3 | Buy | $481.00 | +6,356.38% | Maintains | 7 months ago |
Cyclo Therapeutics IncCYTH | 2 | Buy | $0.95 | +31.76% | Maintains | 10 months ago |
Vision Marine Technologies IncVMAR | 2 | Buy | $2,700.00 | +39,201.31% | Maintains | a year ago |
Shiftpixy IncPIXY | 1 | Buy | $2,160.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.